Share Twitter LinkedIn Facebook Email Rita Sanghvi Mehta, MD, UC Irvine Health, talks about SWOG S0226 – for Metastatic Breast Cancer | Addition of Fulvestrant and Anastrozole Improves Progression-Free and Overall Survival at MOASC 2018.
Enhertu DESTINY-Breast06 Phase III Study the Impact on HR-Positive, HER2-Low Metastatic Breast Cancer Revealed Breast 4 Mins Read
Strategizing Personalized Breast Cancer Treatment: A Promising Overview of Advances and Clinical Applications [39 SLIDES] Breast 4 Mins Read